Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 13/20 | 0.57 |
| ▸ | ABCG2 | Q9UNQ0 | 4/20 | 0.40 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.39 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.39 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.39 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.39 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.39 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.39 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23625854 | 1.00 | PGR (0.57) | PGRABCG2ABCB1HTTGRIN2D | |
| SCHEMBL23625572 | 1.00 | PGR (0.57) | PGRABCG2ABCB1HTTGRIN2D | |
| SCHEMBL24617215 | 1.00 | PGR (0.57) | PGRABCG2ABCB1HTTGRIN2D | |
| SCHEMBL24617284 | 1.00 | PGR (0.57) | PGRABCG2ABCB1HTTGRIN2D | |
| SCHEMBL24617267 | 0.97 | PGR (0.54) | PGRABCG2ABCB1HTT | |
| SCHEMBL24617613 | 0.94 | PGR (0.56) | PGRABCG2ABCB1HTTGRIN2D | |
| SCHEMBL24617303 | 0.94 | PGR (0.64) | PGRABCG2ABCB1HTTGRIN2D | |
| SCHEMBL24617292 | 0.94 | PGR (0.64) | PGRABCG2ABCB1HTTGRIN2D | |
| SCHEMBL23625604 | 0.94 | PGR (0.64) | PGRABCG2ABCB1HTTGRIN2D | |
| SCHEMBL24617282 | 0.94 | PGR (0.64) | PGRABCG2ABCB1HTTGRIN2D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220220084-A1 | ORGANIC COMPOUND, ELECTRONIC COMPONENT AND ELECTRONIC APPARATUS | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2022-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220220084-A1 | ORGANIC COMPOUND, ELECTRONIC COMPONENT AND ELECTRONIC APPARATUS | EXOC4, CYBA, SCO2 | PGR 2373/4885ABCG2 344/4885ABCB1 226/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.